GALECTIN THERAPEU 26 WTS
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for GALECTIN THERAPEU 26 WTS WAR, CUSIP 363225129.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for GALECTIN THERAPEU 26 WTS WAR, CUSIP 363225129.